Enter your login e-mail to the account
Search
Search parameters
Search results
- Novinky vo farmakoterapii: Kategorizácia od 1. januára 2010
Ing. Mgr. Dagmar Hroncová
(12/2009, Information & comments ) - Ticagrelor – a new reversible inhibitor of P2Y12 receptor in the treatment of acute coronary syndromes
prof. MUDr. Vasiľ Hricák, CSc., FESC
(3–4/2013, Drugs & drug classes ) - Antiinfektíva (registrované k 29. 6. 2004)
MUDr. Eva Mikušková
(11/2005, Memorix ) - Treatment options of infection COVID-19
Doc. MUDr. Katarína Gazdíková, PhD., MHA, MPH, mimoriadny profesor
(6/2022, Clinical trials ) - Viral hepatitis in the office of G.P.
Prof. MUDr. Petr Husa, CSc.
(3/2019, Review articles ) - Safety treatment with statins
prof. MUDr. RNDr. Rudolf Pullmann, PhD.
(1/2014, Review articles ) - New treatment options in chronic hepatitis C
Doc. MUDr. Pavol Kristian, PhD., Klinika infektológie a cestovnej medicíny, LF UPJŠ a UNLP, Košice, Doc. MUDr. Mária Belovičová, PhD.
(1/2017, Review articles )
- Drug interactions in psychiatry in theory and in practice
MUDr. Michal Prokeš, PharmDr. Josef Suchopár
(2/2016, Review articles )
- Temsirolimus – mTOR as a new target for the treatmet of advanced cell carcinoma (RCC) and relapsed and/or refractory mantle cell lymphoma (MCL)
doc. PharmDr. Juraj Sýkora, CSc.
(5/2009, Drugs & drug classes )
- PLANTS AND SUBSTANCES FOR TREATMENT OF PERIPHERAL AND CEREBRAL VASCULAR DISORDERS
doc. PharmDr. Juraj Sýkora, CSc., PharmDr. Anita Jančovičová
(1/2008, Drug classes )
- Nové liečivá v EÚ registrované v roku 2014 (IV.)
PharmDr. Peter Stanko, Mgr. Zuzana Černáková
(3-4/2015, New drugs ) - Safety treatment with statins
prof. MUDr. RNDr. Rudolf Pullmann, PhD.
(4/2013, Clinical pharmacy )
- Pharmacological aspects of COVID-19 antivirals from the perspective of drug-drug interactions with antithrombotic treatment
PharmDr. Michal Kolorz, Ph.D.
(1/2023, Main topic ) - Apixaban – a new oral anticoagulant
prof. MUDr. Peter Kubisz, DrSc., doc. MUDr. Ján Staško, PhD., mim. prof., MUDr. Zuzana Jedináková
(1/2014, Drugs & drug classes )